ME1 and metabolic dysfunction-associated steatohepatitis: ME1 is also involved in hepatocarcinogenesis as one of five important prognostic genes (ME1, TP53I3, SOCS2, GADD45G, CYP7A1) associated with NASH-HCC progression [31].